New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
13:09 EDTMDCOThe Medicines Co. drug cangrelor has 'fighting chance,' says Piper Jaffray
Piper Jaffray believes the concerns raised in the briefing documents for The Medicines Company's anti-platelet agent cangrelor are addressable and don't necessarily point to a negative panel outcome. Piper sees a "fighting chance" for the drug and reiterates an Overweight rating on the stock with a $45 price target.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 18, 2015
08:54 EDTMDCOThe Medicines Co. anticipates potential partnership talks
Subscribe for More Information
08:52 EDTMDCOThe Medicines Co. anticipates four U.S. FDA approvals in 2015
08:41 EDTMDCOThe Medicines Co. says not giving financial guidance due to Hospira suit
Subscribe for More Information
07:01 EDTMDCOThe Medicines Co. reports Q4 adjusted EPS 20c, consensus (82c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use